GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6)

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 10, 2012, Pages 3759-3765

  Zampetti, Simona ^a   Capizzi, Marco ^a   Spoletini, Marialuisa ^a   Campagna, Giuseppe ^a   Leto, Gaetano ^a   Cipolloni, Laura ^a   Tiberti, Claudio ^a   Bosi, Emanuele ^b   Falorni, Alberto ^c   Buzzetti, Raffaella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARIETAL CELL ANTIBODY; CELL ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN TYROSINE PHOSPHATASE; STEROID 21 MONOOXYGENASE; THYROID PEROXIDASE; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN DEPENDENCE; LATENT AUTOIMMUNE DIABETES IN ADULTS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN SPECIFIC AUTOIMMUNITY; PANCREAS ISLET BETA CELL; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGE OF ONSET; AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; THYROID GLAND;

EID: 84867507219     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2037     Document Type: Article

References (31)

1. van Deutekom AW, Heine RJ, Simsek S 2008 The islet autoantibody titers: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med 25:117-125 (Pubitemid 351293393)
2. Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C, Capizzi M, Arpi ML, Bazzigaluppi E, Dotta F, Bosi E 2007 High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30:932-938 (Pubitemid 46556589)
3. Desai M, Cull CA, Horton VA, Christie MR, Bonifacio E, Lampasona V, Bingley PJ, Levy JC, Mackay IR, Zimmet P, Holman RR, Clark A 2007 GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. Diabetologia 50:2052-2060 (Pubitemid 47373841)
4. Maioli M, Pes GM, Delitala G, Puddu L, Falorni A, Tolu F, Lampis R, Orrù V, Secchi G, Cicalò AM, Floris R, Madau GF, Pilosu RM, Whalen M, Cucca F 2010 Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults. Eur J Endocrinol 163:541-549
5. Winter WE, Harris N, Schatz D 2002 Type 1 diabetes islet autoantibody markers. Diabetes Technol Ther 4:817-839 (Pubitemid 36172465)
6. Falorni A, Brozzetti A 2005 Diabetes-related antibodies in adult diabetic patients. Best Pract Res Clin Endocrinol Metab 19:119-133 (Pubitemid 40253953)
7. Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A 2000 Increased risk for endocrine autoimmunity in type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol (Oxf) 52:565-573 (Pubitemid 30337081)
8. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissén M, Ehrnström BO, Forsén B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC 1999 Clinical and genetic characteristics of T2DM with and without GAD antibodies. Diabetes 48:150-157 (Pubitemid 29019367)
9. Jin P, Huang G, Lin J, Yang L, Xiang B, Zhou W, Zhou Z 2011 High titer of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults. Clin Endocrinol (Oxf) 74:587-592
10. Chuang LM, Wu HP, Chang CC, Tsai WY, Chang HM, Tai TY, Lin BJ 1996 HLA DRB1/DQA1/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf) 45:631-636 (Pubitemid 26411366)
11. Phillips D, Prentice L, Upadhyaya M, Lunt P, Chamberlain S, Roberts DF, McLachlan S, Smith BR 1991 Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin studies in families not selected for autoimmune thyroid disease. J Clin Endocrinol Metab 72:973-975 (Pubitemid 21921793)
12. Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group 2008 The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care 31:534-538
13. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, Bosi E 1995 Islet autoantibody markers in insulin dependent diabetes: risk assessment strategies yielding high sensitivity. Diabetologia 38:816-822
14. Bingley PJ, Bonifacio E, Mueller PW 2003 Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 52:1128-1136 (Pubitemid 36523346)
15. Tiberti C, Giordano C, Locatelli M, Bosi E, Bottazzo GF, Buzzetti R, Cucinotta D, Galluzzo A, Falorni A, Dotta F 2008 Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the Non-Insulin Requiring Autoimmune Diabetes (NIRAD) study 2. Diabetes 57:1276-1283
16. Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di Pietro S, Songini M, Bonicchio S, Giorgino F, Bonifacio E, Bosi E, Buzzetti R; Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study Group 2010 Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes. Non-Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care 33:104-108
17. Falorni A, Nikoshkov A, Laureti S, Grenbäck E, Hulting AL, Casucci G, Santeusanio F, Brunetti P, Luthman H, Lernmark A 1995 High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab 80:2752-2755
18. Kawasaki E, Nakamura K, Kuriya G, Satoh T, Kuwahara H, Kobayashi M, Abiru N, Yamasaki H, Eguchi K 2010 Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. J Clin Endocrinol Metab 95:707-713
19. Yu L, Boulware DC, Beam CA, Hutton JC, Wenzlau JM, Greenbaum CJ, Bingley PJ, Krischer JP, Sosenko JM, Skyler JS, Eisenbarth GS, Mahon JL; for the Type 1 Diabetes TrialNet Study Group 2012 Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 35:1213-1218
20. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC 2007 The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104:17040-17045 (Pubitemid 350210987)
21. De Block CE, De Leeuw IH, Vertommen JJ, Rooman RP, Du Caju MV, Van Campenhout CM, Weyler JJ, Winnock F, Van Autreve J, Gorus FK; Belgian Diabetes Registry 2001 β-Cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol 126:236-241
22. Abrams P, De Leeuw I, Vertommen J 1996 In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302. Belgian Diabetes Registry. Diabet Med 13:415-419
23. Epidemiology of type 1 diabetes mellitus in Cyprus: Rising incidence at the dawn of the 21st century
24. Blohmé G, Nyström L, Arnqvist HJ, Lithner F, Littorin B, Olsson PO, Scherstén B, Wibell L, Ostman J 1992 Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15-34-year age group in Sweden. Diabetologia 35:56-62
25. Kucera P, Nováková D, Behanová M, Novak J, Tlaskalová-Hogenová H, Andel M 2003 Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA). Clin Exp Immunol 133:139-143
26. Schober E, Granditsch G 1994 IDDM and celiac disease. Diabetes Care 17:1549-1550
27. Rewers M, Liu E, Simmons J, Redondo MJ, Hoffenberg EJ 2004 Celiac disease associated with Type 1 diabetes mellitus. Endocrinol Metab Clin North Am 33:197-214, xi
28. Sánchez JC, Cabrera-Rode E, Sorell L, Galvan JA, Hernandez A, Molina G, Perich PA, Licea ME, Domínguez E, Díaz-Horta O 2007 Celiac disease associated antibodies in persons with latent autoimmune diabetes of adult and type 2 diabetes. Autoimmunity 40:103-107
29. Bonifacio E, Lampasona V, Bernasconi L, Ziegler AG 2000 Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes 49:202-208
30. You S, Chatenoud L 2006 Proinsulin: a unique autoantigen triggering autoimmune diabetes. J Clin Invest 116:3108-3110
31. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD 1995 Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis in the Sjl/j mouse. J Exp Med 182:75-85